Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Argus Health
Boehringer Ingelheim
Farmers Insurance
Cipla
Dow
Mallinckrodt
Federal Trade Commission
Novartis
Fish and Richardson

Generated: December 12, 2017

DrugPatentWatch Database Preview

Rufinamide - Generic Drug Details

« Back to Dashboard

What are the generic sources for rufinamide and what is the scope of rufinamide freedom to operate?

Rufinamide
is the generic ingredient in two branded drugs marketed by Eisai Inc, Glenmark Pharms Ltd, Mylan Pharms Inc, and West-ward Pharms Int, and is included in five NDAs. There are three patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for rufinamide. One supplier is listed for this compound.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Eisai IncBANZELrufinamideTABLET;ORAL021911-002Nov 14, 2008ABRXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Eisai IncBANZELrufinamideSUSPENSION;ORAL201367-001Mar 3, 2011RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Eisai IncBANZELrufinamideTABLET;ORAL021911-003Nov 14, 2008ABRXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Eisai IncBANZELrufinamideTABLET;ORAL021911-001Nov 14, 2008DISCNYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Glenmark Pharms LtdRUFINAMIDErufinamideTABLET;ORAL205075-002May 16, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Glenmark Pharms LtdRUFINAMIDErufinamideTABLET;ORAL205075-001May 16, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
West-ward Pharms IntRUFINAMIDErufinamideTABLET;ORAL204988-001May 16, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Eisai IncBANZELrufinamideSUSPENSION;ORAL201367-001Mar 3, 2011RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Mylan Pharms IncRUFINAMIDErufinamideTABLET;ORAL205095-001May 16, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Eisai IncBANZELrufinamideTABLET;ORAL021911-001Nov 14, 2008DISCNYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
US Department of Justice
UBS
Cipla
Deloitte
Express Scripts
Fish and Richardson
Chubb
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot